|
1
|
Canning M, Guo G, Yu M, Myint C, Groves
MW, Byrd JK and Cui Y: Heterogeneity of the head and neck squamous
cell carcinoma immune landscape and its impact on immunotherapy.
Front Cell Dev Biol. 7:522019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ribeiro IP, Caramelo F, Esteves L, Menoita
J, Marques F, Barroso L, Miguéis J, Melo JB and Carreira IM:
Genomic predictive model for recurrence and metastasis development
in head and neck squamous cell carcinoma patients. Sci Rep.
7:138972017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Visscher AV and Manni JJ: Routine
long-term follow-up in patients treated with curative intent for
squamous cell carcinoma of the larynx, pharynx, and oral cavity.
Does it make sense? Arch Otolaryngol Head Neck Surg. 120:934–939.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Miguel-Luken MJ, Chaves-Conde M and
Carnero A: A genetic view of laryngeal cancer heterogeneity. Cell
Cycle. 15:1202–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torrente MC, Rodrigo JP, Haigentz M Jr,
Dikkers FG, Rinaldo A, Takes RP, Olofsson J and Ferlito A: Human
papillomavirus infections in laryngeal cancer. Head Neck.
33:581–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thariat J, Vignot S, Lapierre A, Falk AT,
Guigay J, Van Obberghen-Schilling E and Milano G: Integrating
genomics in head and neck cancer treatment: Promises and pitfalls.
Crit Rev Oncol Hematol. 95:397–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kujawski M, Rydzanicz M, Sarlomo-Rikala M,
Gabriel A and Szyfter K: Chromosome alterations reflect clonal
evolution in squamous cell carcinoma of the larynx. Med Sci Monit.
8:BR279–BR282. 2002.PubMed/NCBI
|
|
8
|
American Joint Committee on Cancer
(AJCC)-TNM staging classification. 7th. Springer; New York, NY:
2010
|
|
9
|
Ribeiro IP, Marques F, Caramelo F, Ferrão
J, Prazeres H, Julião MJ, Rifi W, Savola S, de Melo JB, Baptista IP
and Carreira IM: Genetic imbalances detected by multiplex
ligation-dependent probe amplification in a cohort of patients with
oral squamous cell carcinoma-the first step towards clinical
personalized medicine. Tumour Biol. 35:4687–4695. 2014.PubMed/NCBI
|
|
10
|
Ribeiro IP, Marques F, Caramelo F, Pereira
J, Patrício M, Prazeres H, Ferrão J, Julião MJ, Castelo-Branco M,
de Melo JB, et al: Genetic gains and losses in oral squamous cell
carcinoma: Impact on clinical management. Cell Oncol (Dordr).
37:29–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ribeiro IP, Caramelo F, Marques F,
Domingues A, Mesquita M, Barroso L, Prazeres H, Julião MJ, Baptista
IP, Ferreira A, et al: WT1, MSH6, GATA5 and PAX5 as epigenetic oral
squamous cell carcinoma biomarkers-a short report. Cell Oncol
(Dordr). 39:573–582. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ribeiro IP, Caramelo F, Esteves L,
Oliveira C, Marques F, Barroso L, Melo JB and Carreira IM: Genomic
and epigenetic signatures associated with survival rate in oral
squamous cell carcinoma patients. J Cancer. 9:1885–1895. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jarmuz-Szymczak M, Pelinska K,
Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D,
Szaumkessel M, Marszalek A, Janiszewska J, Kiwerska K, et al:
Heterogeneity of 11q13 region rearrangements in laryngeal squamous
cell carcinoma analyzed by microarray platforms and fluorescence in
situ hybridization. Mol Biol Rep. 40:4161–4171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Järvinen AK, Autio R, Haapa-Paananen S,
Wolf M, Saarela M, Grénman R, Leivo I, Kallioniemi O, Mäkitie AA
and Monni O: Identification of target genes in laryngeal squamous
cell carcinoma by high-resolution copy number and gene expression
microarray analyses. Oncogene. 25:6997–7008. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Giefing M, Martin-Subero JI, Kiwerska K,
Jarmuz M, Grenman R, Siebert R and Szyfter K: Characterization of
homozygous deletions in laryngeal squamous cell carcinoma cell
lines. Cancer Genet Cytogenet. 184:38–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giefing M, Zemke N, Brauze D,
Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M, Pelinska K,
Kiwerska K, Tönnies H, Grenman R, et al: High resolution ArrayCGH
and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor
suppressor gene candidates in laryngeal squamous cell carcinoma.
Genes Chromosomes Cancer. 50:154–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cancer Genome Atlas Network: Comprehensive
genomic characterization of head and neck squamous cell carcinomas.
Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Califano J, van der Riet P, Westra W,
Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B,
Koch W and Sidransky D: Genetic progression model for head and neck
cancer: Implications for field cancerization. Cancer Res.
56:2488–2492. 1996.PubMed/NCBI
|
|
19
|
Lee DJ, Schonleben F, Banuchi VE, Qiu W,
Close LG, Assaad AM and Su GH: Multiple tumor-suppressor genes on
chromosome 3p contribute to head and neck squamous cell carcinoma
tumorigenesis. Cancer Biol Ther. 10:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lawson DA, Kessenbrock K, Davis RT,
Pervolarakis N and Werb Z: Tumour heterogeneity and metastasis at
single-cell resolution. Nat Cell Biol. 20:1349–1360. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim WY and Kaelin WG: Role of VHL gene
mutation in human cancer. J Clin Oncol. 22:4991–5004. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Zhou X, Wang B, Zhang K, Liu S,
Yue K, Zhang L and Wang X: Loss of VHL expression contributes to
epithelial-mesenchymal transition in oral squamous cell carcinoma.
Oral Oncol. 50:809–817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pal SK, Nguyen CT, Morita KI, Miki Y,
Kayamori K, Yamaguchi A and Sakamoto K: THBS1 is induced by TGFB1
in the cancer stroma and promotes invasion of oral squamous cell
carcinoma. J Oral Pathol Med. 45:730–739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel PH, Chadalavada RS, Chaganti RS and
Motzer RJ: Targeting von Hippel-Lindau pathway in renal cell
carcinoma. Clin Cancer Res. 12:7215–7220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beroukhim R, Brunet JP, Di Napoli A, Mertz
KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, et
al: Patterns of gene expression and copy-number alterations in
von-hippel lindau disease-associated and sporadic clear cell
carcinoma of the kidney. Cancer Res. 69:4674–4681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang T, Srivastava S, Hartman M, Buhari
SA, Chan CW, Iau P, Khin LW, Wong A, Tan SH, Goh BC and Lee SC:
High expression of intratumoral stromal proteins is associated with
chemotherapy resistance in breast cancer. Oncotarget.
7:55155–55168. 2016.PubMed/NCBI
|
|
27
|
Van Driessche A, Berneman ZN and Van
Tendeloo VF: Active specific immunotherapy targeting the Wilms'
tumor protein 1 (WT1) for patients with hematological malignancies
and solid tumors: Lessons from early clinical trials. Oncologist.
17:250–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
